Background: The risk for contrast-induced nephropathy (CIN) after intra-arterial application of an iodine-based contrast material is unknown for patients with chronic kidney disease (CKD) and peripheral arterial disease (PAD).
Purpose: To investigate the incidence of CIN in patients with CKD and PAD.
Material And Methods: This retrospective study was approved by the local ethics committee.